All Stories

  1. Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures
  2. What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial
  3. Scopolamine's Anticholinergic Effects on EEG Spectral, Aperiodic, Complexity, Microstates, and Heart Rate Variability
  4. A qualitative exploration of community pharmacist views on providing a mental health and well-being intervention for long-term condition patients
  5. Mapping Neuroinflammation With Diffusion-Weighted Magnetic Resonance Imaging: A Randomized Crossover Study
  6. Early experiences of the End of Life Choice Act 2019 amongst assisted dying practitioners in Aotearoa New Zealand
  7. Rethinking measurement: a preliminary study of mental health literacy among college students
  8. Practitioners’ attitudes and approaches to assessing comorbid depression among patients seeking assisted dying in New Zealand
  9. The Cost-Effectiveness of Mindfulness-Based Interventions for Medical Students: A Scoping Review
  10. The Identification and Management of Subthreshold Depression and Anxiety in Primary Care for People With Long‐Term Conditions
  11. The Effects of Neuroinflammation Induced by Typhoid Vaccine on Resting and Task‐Based Electroencephalography
  12. Understanding the scope of Consultation-Liaison Psychiatry referrals in a general hospital setting in New Zealand
  13. Advancing health coaching: A comparative study of large language model and health coaches
  14. A survey of the psychiatric care provided for children and young people in general hospital settings in New Zealand
  15. Multimodal creativity assessments following acute and sustained microdosing of lysergic acid diethylamide
  16. LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder
  17. Transforming a Psychiatry Curriculum: Narrative Review of Essential Elements
  18. Nitrous oxide myelopathy: a case series
  19. LSD increases sleep duration the night after microdosing
  20. Mindfulness and Religiosity: Four Propositions to Advance a More Integrative Pedagogical Approach
  21. PAM trial protocol: a randomised feasibility study of psychedelic microdosing–assisted meaning-centred psychotherapy in advanced stage cancer patients
  22. Towards Personalised Mood Prediction and Explanation for Depression from Biophysical Data
  23. Pacific Cultural Enhancement of Mindfulness-Based Cognitive Therapy: Insights from Clinical and Cultural Experts
  24. An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)
  25. Perspectives from gambling expert stakeholders in relation to electronic gaming machines in New Zealand
  26. Broadening the state of play – the second national survey of Consultation-Liaison Psychiatry services in New Zealand, 2021
  27. From the chemical imbalance to the power imbalance: A psychiatry trainee’s perspectives on service-user supervision
  28. Detection of Neuroinflammation Induced by Typhoid Vaccine Using Quantitative Magnetization Transfer MR: A Randomized Crossover Study
  29. A survey of the psychiatric care provided for medically ill older adults in general hospitals in New Zealand
  30. Towards Personalised Depression Modelling and Explanation from Wearable Data
  31. Towards integrated Consultation-Liaison Psychiatry for older adults in New Zealand
  32. Cultural Factors in Behavioral Health Assessment
  33. The perceptions of cancer health-care practitioners in New Zealand and the USA toward psychedelic-assisted therapy with cancer patients: A cross-sectional survey
  34. A randomized, double-blind, placebo-controlled, hybrid parallel-arm study of low-dose naltrexone as an adjunctive anti-inflammatory treatment for major depressive disorder
  35. A Randomized Controlled Trial of Intravenous Scopolamine Versus Active-Placebo Glycopyrrolate in Patients With Major Depressive Disorder
  36. A national study of the mental health literacy of community pharmacists
  37. Mindfulness-Based Cognitive Therapy for Stress Reduction in Family Carers of People Living with Dementia: A Systematic Review
  38. Brain temperature as an indicator of neuroinflammation induced by typhoid vaccine: Assessment using whole-brain magnetic resonance spectroscopy in a randomised crossover study
  39. Using Acoustic Speech Patterns From Smartphones to Investigate Mood Disorders: Scoping Review
  40. Depression and suicidal ideation among dental students of Southern Saudi Arabia: A cross sectional study
  41. Cancer Healthcare Workers’ Perceptions toward Psychedelic-Assisted Therapy: A Preliminary Investigation
  42. Concurrent Disorders and Decision-Making in Electronic Gaming Machine Gamblers
  43. FACT effectiveness in primary care; a single visit RCT for depressive symptoms
  44. MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers
  45. A qualitative and quantitative account of patient’s experiences of ketamine and its antidepressant properties
  46. Using Acoustic Speech Patterns From Smartphones to Investigate Mood Disorders: Scoping Review (Preprint)
  47. Ketamine improves short-term plasticity in depression by enhancing sensitivity to prediction errors
  48. Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder
  49. The state of play – the first national survey of consultation-liaison psychiatry services in New Zealand
  50. A randomised, double-blind, active placebo-controlled, parallel groups, dose-response study of scopolamine hydrobromide (4–6 μg/kg) in patients with major depressive disorder
  51. A proof-of-principle study of the short-term effects of MDMA (3,4-methylenedioxymethamphetamine) on tinnitus and neural connectivity.
  52. Nonepileptic seizures in individuals attending neurological services in New Zealand
  53. The multi-dimensional matrix for consultation-liaison psychiatry (mMAX-LP)
  54. Impact of Using a 3D Visual Metaphor Serious Game to Teach History-Taking Content to Medical Students: Longitudinal Mixed Methods Pilot Study
  55. Evaluating Commonalities Across Medically Unexplained Symptoms
  56. Impact of Using a 3D Visual Metaphor Serious Game to Teach History-Taking Content to Medical Students: Longitudinal Mixed Methods Pilot Study (Preprint)
  57. Motivations, Expectations and Experiences in Being a Mental Health Helplines Volunteer
  58. Peak visual gamma frequency is modified across the healthy menstrual cycle
  59. Do suicide characteristics differ by age in older people?
  60. Late-Life Suicide in Terminal Cancer: A Rational Act or Underdiagnosed Depression?
  61. Predictors for repeat self-harm and suicide among older people within 12 months of a self-harm presentation
  62. Social anxiety apps: a systematic review and assessment of app descriptors across mobile store platforms
  63. Tips and Traps: Lessons From Codesigning a Clinician E-Monitoring Tool for Computerized Cognitive Behavioral Therapy
  64. Optimization of High Definition Transcranial Direct Current Stimulation (HDtDCS) For Tinnitus Relief
  65. A brief treatment for fear of heights
  66. The resource utilisation of medically unexplained physical symptoms
  67. Death wishes among older people assessed for home support and long-term aged residential care
  68. Who Are the Elderly Who Want to End Their Lives?
  69. Elderly disempowerment and do the means justify the end?
  70. Understanding the Progression from Physical Illness to Suicidal Behavior: A Case Study Based on a Newly Developed Conceptual Model
  71. Enhancing suicide risk assessment: a novel visual metaphor learning tool
  72. Psychiatric comorbidity in psychogenic nonepileptic seizures compared with epilepsy
  73. The resource utilisation associated with medically unexplained physical symptoms
  74. Late-life suicide: Insight on motives and contributors derived from suicide notes
  75. Intensity, Duration, and Location of High-Definition Transcranial Direct Current Stimulation for Tinnitus Relief
  76. Visualizing psychiatric formulation
  77. Medical examiner and coroner reports: uses and limitations in the epidemiology and prevention of late-life suicide
  78. Late-life homicide-suicide: a national case series in New Zealand
  79. Non-graduate and graduate entry medical students attitudes to psychiatry
  80. White matter microstructural abnormalities in the frontal lobe of adults with antisocial personality disorder
  81. Practical Guidelines for Managing Patients with 22q11.2 Deletion Syndrome
  82. Electroconvulsive Therapy Training and Confidence in Administration
  83. White matter integrity in Asperger syndrome: A preliminary diffusion tensor magnetic resonance imaging study in adults
  84. Schizophrenia and 22q11.2 Deletion Syndrome
  85. Neuroanatomical correlates of psychosis in temporal lobe epilepsy: voxel-based morphometry study
  86. White matter integrity in Asperger syndrome: a preliminary diffusion tensor magnetic resonance imaging study in adults
  87. White matter microstructure in 22q11 deletion syndrome: a pilot diffusion tensor imaging and voxel-based morphometry study of children and adolescents
  88. Is there an increased prevalence of autistic spectrum disorders in people with 22q11 Deletion Syndrome?
  89. White matter microstructure in children with Velocardiofacial Syndrome: A Diffusion Tensor Imaging and Voxel Based Morphometry study
  90. Neuropsychiatry of epilepsy
  91. Risk factors for violence: an audit on the effect of a tutorial on risk assessment
  92. Velo-Cardio-Facial Syndrome/22q11 Deletion Syndrome